Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Beximco Pharmaceuticals Limited Sponsored GDR RegS ( (GB:BXP) ) just unveiled an announcement.
Beximco Pharmaceuticals Limited has announced the payment of a 40% cash dividend to its shareholders for the fiscal year ending June 2024. This dividend, approved at the AGM, reflects the company’s robust financial health and commitment to delivering shareholder value, strengthening its position in the pharmaceutical industry and potentially enhancing investor confidence.
More about Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Limited, established in 1976, is a leading manufacturer and exporter of generic pharmaceutical products based in Bangladesh. The company offers a wide portfolio encompassing tablets, capsules, liquids, semi-solids, and various specialized delivery systems like inhalers and injectables. Beximco Pharma also engages in contract manufacturing for multinational corporations and is certified by major global regulatory bodies, operating in more than 50 countries with over 6,000 employees.
YTD Price Performance: -1.28%
Average Trading Volume: 50,741
Technical Sentiment Consensus Rating: Hold
For detailed information about BXP stock, go to TipRanks’ Stock Analysis page.
